1. Scott PP, Scott WW Jr, Siegelman SS. Amyloidosis: an overview. Semin Roentgenol. 1986. 21:103–112.
2. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore). 1975. 54:271–299.
3. Glenner GG, Ein D, Terry WD. The immunoglobulin origin of amyloid. Am J Med. 1972. 52:141–147.
4. Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR. Amyloidosis. Best Pract Res Clin Haematol. 2005. 18:709–727.
5. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997. 337:898–909.
6. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005. 79:319–328.
7. Moon W, Lee OY, Cho YJ, et al. The endoscopic findings and clinical characteristics of gastrointestinal amyloidosis. Korean J Gastrointest Endosc. 2005. 31:216–220.
8. Leem JM, Choi JH, Park NG, et al. A case of gastrointestinal amyloidosis presenting with hematochezia. Korean J Gastrointest Endosc. 2002. 25:38–42.
9. Levy DJ, Franklin GO, Rosenthal WS. Gastrointestinal bleeding and amyloidosis. Am J Gastroenterol. 1982. 77:422–426.
10. Barth WF, Glenner GG, Waldmann TA, Zelis RF. Primary amyloidosis. Ann Intern Med. 1968. 69:787–805.
11. Chitkara NL, Chugh TD, Chhuttani PN, Chugh KS. Secondary amyloidosis. Indian J Pathol Bacteriol. 1965. 8:285–293.
12. Patel SA, al-Haddadin D, Schopp J, Cantave I, Duarte B, Watkins JL. Gastrointestinal manifestations of amyloidosis: a case of diverticular perforation. Am J Gastroenterol. 1993. 88:578–582.
13. Puchtler H, Sweat F, Levine M. On the binding of congo red by amyloid. J Histochem Cytochem. 1962. 10:355–364.
14. Usui M, Matsuda S, Suzuki H, Hirata K, Ogura Y, Shiraishi T. Gastric amyloidosis with massive bleeding requiring emergency surgery. J Gastroenterol. 2000. 35:924–928.
15. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997. 336:1202–1207.
16. Takahashi A, Matsumoto J, Nishimura S, et al. Improvement of endoscopic and histologic findings of AA-type gastrointestinal amyloidosis by treatment with dimethyl sulfoxide and prednisolone. Gastroenterol Jpn. 1985. 20:143–147.
17. Cohen HJ, Lessin LS, Hallal J, Burkholder P. Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome. Ann Intern Med. 1975. 82:466–473.
18. Redleaf PD, Davis RB, Kucinski C, Hoilund L, Gans H. Amyloidosis with and unusual bleeding diathesis; observations on the use of epsilon amino caproic acid. Ann Intern Med. 1963. 58:347–354.
19. Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Exp Rheumatol. 2007. 25:518–522.